| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Mar 29, 2024 | Option Exercise | $3.00 | 5,209 | 15,627 | 98,459 | Apr 02, 2024, 04:05 PM | |
| GLYC | GLYCOMIMETICS INC | Andrews Patricia S | Director | Dec 29, 2023 | Option Exercise | $2.36 | 5,191 | 12,251 | 58,608 | Jan 02, 2024, 04:05 PM | |
| GLYC | GLYCOMIMETICS INC | King Rachel K. | Director | Dec 29, 2023 | Option Exercise | $2.36 | 4,238 | 10,002 | 511,860 | Jan 02, 2024, 04:05 PM | |
| GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Dec 29, 2023 | Option Exercise | $2.36 | 5,827 | 13,752 | 20,244 | Jan 02, 2024, 04:05 PM | |
| GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Sep 30, 2023 | Option Exercise | $1.50 | 9,167 | 13,751 | 14,417 | Oct 03, 2023, 04:15 PM | |
| GLYC | GLYCOMIMETICS INC | Rock Edwin | Chief Medical Officer | Sep 21, 2023 | Buy | $1.38 | 35,000 | 48,300 | 345,000 | Sep 25, 2023, 04:21 PM | |
| GLYC | GLYCOMIMETICS INC | Rock Edwin | Chief Medical Officer | Sep 22, 2023 | Buy | $1.38 | 30,403 | 41,956 | 375,403 | Sep 25, 2023, 04:21 PM | |
| GLYC | GLYCOMIMETICS INC | Koenig Scott | Director | Jun 01, 2023 | Option Exercise | $0.60 | 21,000 | 12,600 | 36,750 | Jun 02, 2023, 04:10 PM | |
| GLYC | GLYCOMIMETICS INC | Hahn Brian M. | SVP Finance, CFO | May 17, 2023 | Sale | $1.95 | 3,700 | 7,215 | 53,143 | May 18, 2023, 04:27 PM | |
| GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | May 10, 2023 | Buy | $1.56 | 30,000 | 46,800 | 93,250 | May 11, 2023, 05:08 PM | |
| GLYC | GLYCOMIMETICS INC | Johnson Bruce S | SVP & Chief Commercial Officer | May 08, 2023 | Buy | $1.57 | 13,500 | 21,195 | 138,980 | May 09, 2023, 05:00 PM | |
| GLYC | GLYCOMIMETICS INC | Stichting Administratiekantoor Westend | 10% Owner | Feb 24, 2023 | Buy | $1.70 | 100,000 | 170,000 | 8,589,064 | Feb 28, 2023, 05:33 PM | |
| GLYC | GLYCOMIMETICS INC | Invus Public Equities, L.P. | 10% Owner | Feb 21, 2023 | Buy | $1.85 | 50,000 | 92,500 | 8,139,064 | Feb 23, 2023, 06:23 PM | |
| GLYC | GLYCOMIMETICS INC | Artal Group S.A. | 10% Owner | Feb 22, 2023 | Buy | $1.79 | 150,000 | 268,995 | 8,289,064 | Feb 23, 2023, 06:23 PM | |
| GLYC | GLYCOMIMETICS INC | Wittouck Amaury | 10% Owner | Feb 23, 2023 | Buy | $1.75 | 200,000 | 350,760 | 8,489,064 | Feb 23, 2023, 06:23 PM | |
| GLYC | GLYCOMIMETICS INC | Stichting Administratiekantoor Westend | 10% Owner | Feb 17, 2023 | Buy | $1.71 | 200,000 | 341,000 | 8,089,064 | Feb 17, 2023, 05:29 PM | |
| GLYC | GLYCOMIMETICS INC | Invus Public Equities Advisors, LLC | 10% Owner | Feb 15, 2023 | Buy | $2.16 | 1,000,000 | 2,155,800 | 7,573,798 | Feb 17, 2023, 05:29 PM | |
| GLYC | GLYCOMIMETICS INC | Artal International S.C.A. | 10% Owner | Feb 16, 2023 | Buy | $1.68 | 315,266 | 531,129 | 7,889,064 | Feb 17, 2023, 05:29 PM | |
| GLYC | GLYCOMIMETICS INC | Invus Public Equities, L.P. | 10% Owner | Feb 09, 2023 | Buy | $3.24 | 11,451 | 37,123 | 6,573,798 | Feb 13, 2023, 05:45 PM | |
| GLYC | GLYCOMIMETICS INC | Koenig Scott | Director | Jan 27, 2023 | Option Exercise | $2.55 | 10,500 | 26,775 | 15,750 | Jan 30, 2023, 04:13 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Jan 26, 2023 | Sale | $3.12 | 1,351,092 | 4,213,786 | 2,237,196 | Jan 27, 2023, 05:15 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Jan 25, 2023 | Sale | $3.26 | 358,371 | 1,169,687 | 4,379,242 | Jan 27, 2023, 05:15 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Jan 25, 2023 | Sale | $3.26 | 293,645 | 958,428 | 3,588,288 | Jan 27, 2023, 05:15 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Jan 26, 2023 | Sale | $3.12 | 1,648,908 | 5,142,614 | 2,730,334 | Jan 27, 2023, 05:15 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Jan 05, 2023 | Sale | $2.76 | 39,223 | 108,201 | 4,737,613 | Jan 06, 2023, 06:35 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Jan 05, 2023 | Sale | $2.76 | 32,139 | 88,659 | 3,881,933 | Jan 06, 2023, 06:35 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Dec 30, 2022 | Sale | $3.02 | 66,690 | 201,404 | 4,928,974 | Jan 04, 2023, 05:26 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Dec 30, 2022 | Sale | $3.02 | 54,645 | 165,028 | 4,038,732 | Jan 04, 2023, 05:26 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Jan 03, 2023 | Sale | $2.99 | 96,084 | 287,301 | 4,832,890 | Jan 04, 2023, 05:26 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Jan 03, 2023 | Sale | $2.99 | 78,730 | 235,411 | 3,960,002 | Jan 04, 2023, 05:26 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Jan 04, 2023 | Sale | $2.91 | 56,054 | 163,100 | 4,776,836 | Jan 04, 2023, 05:26 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Jan 04, 2023 | Sale | $2.91 | 45,930 | 133,643 | 3,914,072 | Jan 04, 2023, 05:26 PM | |
| GLYC | GLYCOMIMETICS INC | Rock Edwin | Chief Medical Officer | Dec 22, 2022 | Buy | $2.25 | 110,000 | 247,500 | 310,000 | Dec 27, 2022, 06:41 PM | |
| GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Nov 17, 2022 | Buy | $1.87 | 20,000 | 37,400 | 63,250 | Nov 18, 2022, 04:01 PM | |
| GLYC | GLYCOMIMETICS INC | Rock Edwin | Chief Medical Officer | Nov 14, 2022 | Buy | $1.43 | 100,000 | 143,000 | 100,000 | Nov 16, 2022, 04:26 PM | |
| GLYC | GLYCOMIMETICS INC | Rock Edwin | Chief Medical Officer | Nov 15, 2022 | Buy | $1.66 | 100,000 | 166,000 | 200,000 | Nov 16, 2022, 04:26 PM | |
| GLYC | GLYCOMIMETICS INC | PEARSON TIMOTHY R | Director | Nov 11, 2022 | Buy | $1.29 | 19,400 | 25,026 | 24,650 | Nov 14, 2022, 04:14 PM | |
| GLYC | GLYCOMIMETICS INC | Semerjian Harout | Chief Executive Officer | Nov 11, 2022 | Buy | $1.29 | 25,000 | 32,250 | 25,000 | Nov 14, 2022, 04:13 PM | |
| GLYC | GLYCOMIMETICS INC | Hahn Brian M. | SVP Finance, CFO | Nov 11, 2022 | Buy | $1.06 | 20,000 | 21,200 | 56,843 | Nov 14, 2022, 04:13 PM | |
| GLYC | GLYCOMIMETICS INC | Magnani John L. | SVP of Research, CSO | Nov 11, 2022 | Buy | $1.17 | 45,045 | 52,703 | 366,078 | Nov 14, 2022, 04:11 PM | |
| GLYC | GLYCOMIMETICS INC | Girard Armand | SVP, Chief Business Officer | Nov 11, 2022 | Buy | $1.05 | 6,500 | 6,825 | 29,161 | Nov 14, 2022, 04:04 PM | |
| GLYC | GLYCOMIMETICS INC | Magnani John L. | SVP of Research, CSO | Mar 09, 2022 | Sale | $1.09 | 3,227 | 3,517 | 321,033 | Mar 10, 2022, 05:06 PM | |
| GLYC | GLYCOMIMETICS INC | Girard Armand | SVP, Chief Business Officer | Mar 09, 2022 | Sale | $1.09 | 2,339 | 2,550 | 22,661 | Mar 10, 2022, 05:05 PM | |
| GLYC | GLYCOMIMETICS INC | Hahn Brian M. | SVP Finance, CFO | Mar 09, 2022 | Sale | $1.09 | 2,917 | 3,180 | 36,843 | Mar 10, 2022, 05:03 PM | |
| GLYC | GLYCOMIMETICS INC | Andrews Patricia S | Director | Nov 16, 2021 | Buy | $2.05 | 40,000 | 82,000 | 45,250 | Nov 18, 2021, 04:05 PM | |
| GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Dec 28, 2020 | Sale | $2.21 | 214,997 | 475,648 | 440,240 | Dec 30, 2020, 04:00 PM | |
| GLYC | GLYCOMIMETICS INC | Hahn Brian M. | SVP Finance, CFO | Dec 16, 2020 | Option Exercise | $1.12 | 5,260 | 5,891 | 5,260 | Dec 17, 2020, 04:00 PM | |
| GLYC | GLYCOMIMETICS INC | BVF II GP LLC | See Explanation of Responses | Nov 04, 2020 | Buy | $2.60 | 1,266,737 | 3,293,516 | 4,980,812 | Nov 06, 2020, 06:33 PM | |
| GLYC | GLYCOMIMETICS INC | BVF I GP LLC | See Explanation of Responses | Oct 30, 2020 | Buy | $2.75 | 932,612 | 2,564,683 | 4,306,320 | Nov 03, 2020, 04:44 PM | |
| GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Mar 09, 2020 | Buy | $3.40 | 20,000 | 68,000 | 38,000 | Mar 10, 2020, 06:12 PM | |
| GLYC | GLYCOMIMETICS INC | Magnani John L. | SVP of Research, CSO | Jan 06, 2020 | Option Exercise | $1.12 | 106,983 | 119,821 | 289,760 | Jan 06, 2020, 06:23 PM | |
| GLYC | GLYCOMIMETICS INC | Magnani John L. | SVP of Research, CSO | Dec 20, 2019 | Option Exercise | $1.12 | 106,984 | 119,822 | 182,777 | Dec 23, 2019, 04:13 PM | |
| GLYC | GLYCOMIMETICS INC | BVF INC/IL | 10% Owner | Sep 05, 2019 | Buy | $3.18 | 1,668,746 | 5,309,950 | 3,639,935 | Sep 09, 2019, 04:49 PM | |
| GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Aug 13, 2019 | Buy | $3.18 | 10,000 | 31,800 | 18,000 | Aug 15, 2019, 04:03 PM | |
| GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Aug 06, 2019 | Option Exercise | $1.12 | 166,759 | 186,770 | 307,144 | Aug 07, 2019, 04:29 PM | |
| GLYC | GLYCOMIMETICS INC | Magnani John L. | SVP of Research, CSO | Oct 16, 2018 | Sale | $14.01 | 14,200 | 198,942 | 86,593 | Oct 18, 2018, 05:36 PM | |
| GLYC | GLYCOMIMETICS INC | Magnani John L. | SVP of Research, CSO | Oct 17, 2018 | Sale | $14.00 | 7,273 | 101,822 | 79,320 | Oct 18, 2018, 05:36 PM | |
| GLYC | GLYCOMIMETICS INC | Magnani John L. | SVP of Research, CSO | Oct 18, 2018 | Sale | $14.02 | 3,527 | 49,449 | 75,793 | Oct 18, 2018, 05:36 PM | |
| GLYC | GLYCOMIMETICS INC | Hahn Brian M. | CFO | Jun 11, 2018 | Option Exercise | $14.42 | 24,605 | 354,875 | 19,345 | Jun 12, 2018, 05:54 PM | |
| GLYC | GLYCOMIMETICS INC | Magnani John L. | SVP of Research, CSO | May 23, 2018 | Option Exercise | $0.33 | 1,491 | 492 | 100,793 | May 24, 2018, 05:11 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | May 10, 2018 | Sale | $0.65 | 523,991 | 339,659 | 5,001,197 | May 11, 2018, 05:02 PM | |
| GLYC | GLYCOMIMETICS INC | BARRIS PETER J | 10% Owner | May 10, 2018 | Option Exercise | $0.65 | 523,991 | 339,659 | 5,001,197 | May 11, 2018, 05:01 PM | |
| GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | May 10, 2018 | Option Exercise | $0.65 | 523,991 | 339,659 | 5,001,197 | May 11, 2018, 05:00 PM | |
| GLYC | GLYCOMIMETICS INC | NEW ENTERPRISE ASSOCIATES 10 L P | 10% Owner | May 10, 2018 | Sale | $0.65 | 523,991 | 339,659 | 5,001,197 | May 11, 2018, 05:00 PM | |
| GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Development, CMO | Dec 08, 2017 | Sale | $15.01 | 2,000 | 30,020 | 148,615 | Dec 12, 2017, 04:14 PM | |
| GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Development, CMO | Sep 18, 2017 | Sale | $13.00 | 2,000 | 26,000 | 150,615 | Sep 18, 2017, 06:15 PM | |
| GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Jun 15, 2017 | Option Exercise | $11.27 | 3,000 | 33,810 | 8,000 | Jun 16, 2017, 05:14 PM | |
| GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Development, CMO | May 25, 2017 | Sale | $15.57 | 2,000 | 31,140 | 152,615 | May 30, 2017, 04:07 PM | |
| GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Development, CMO | May 19, 2017 | Sale | $12.14 | 2,000 | 24,280 | 154,615 | May 22, 2017, 09:23 PM | |
| GLYC | GLYCOMIMETICS INC | Magnani John L. | SVP of Research, CSO | May 10, 2017 | Option Exercise | $1.12 | 8,928 | 9,999 | 99,302 | May 11, 2017, 04:00 PM | |
| GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Dec 20, 2016 | Buy | $6.01 | 5,000 | 30,050 | 5,000 | Dec 21, 2016, 04:23 PM | |
| GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Development, CMO | Oct 03, 2016 | Sale | $7.00 | 4,000 | 28,001 | 156,715 | Oct 04, 2016, 04:22 PM | |
| GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Development, CMO | Jul 20, 2016 | Sale | $8.00 | 2,000 | 16,000 | 160,615 | Jul 21, 2016, 05:27 PM | |
| GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Development, CMO | Jul 06, 2016 | Sale | $6.68 | 6,796 | 45,397 | 162,615 | Jul 06, 2016, 05:07 PM | |
| GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Development, CMO | Jul 01, 2016 | Sale | $7.40 | 5,068 | 37,503 | 179,547 | Jul 06, 2016, 05:07 PM | |
| GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Development, CMO | Jul 05, 2016 | Sale | $7.01 | 10,136 | 71,053 | 169,411 | Jul 06, 2016, 05:07 PM | |
| GLYC | GLYCOMIMETICS INC | Baldwin John J. | Director | Jun 29, 2016 | Option Exercise | $1.12 | 605 | 678 | 1,210 | Jul 01, 2016, 11:43 AM | |
| GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Mar 04, 2016 | Buy | $4.77 | 10,397 | 49,630 | 11,497 | Mar 07, 2016, 08:03 AM | |
| GLYC | GLYCOMIMETICS INC | TOP FRANKLIN H JR | Director | Feb 05, 2016 | Option Exercise | $1.12 | 11,689 | 13,092 | 12,294 | Feb 12, 2016, 03:30 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Nov 16, 2015 | Option Exercise | $0.63 | 9,897 | 6,240 | 4,491,203 | Nov 18, 2015, 02:20 PM | |
| GLYC | GLYCOMIMETICS INC | BARRIS PETER J | 10% Owner | Nov 16, 2015 | Option Exercise | $0.63 | 9,897 | 6,240 | 4,491,203 | Nov 18, 2015, 02:20 PM | |
| GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Nov 16, 2015 | Option Exercise | $0.63 | 9,897 | 6,240 | 4,491,203 | Nov 18, 2015, 02:19 PM | |
| GLYC | GLYCOMIMETICS INC | NEW ENTERPRISE ASSOCIATES 10 L P | 10% Owner | Nov 16, 2015 | Sale | $0.63 | 9,897 | 6,240 | 4,491,203 | Nov 18, 2015, 02:18 PM | |
| GLYC | GLYCOMIMETICS INC | Hahn Brian M. | CFO | Feb 27, 2015 | Option Exercise | $1.12 | 5,000 | 5,600 | 14,085 | Mar 03, 2015, 04:08 PM | |
| GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Feb 24, 2015 | Option Exercise | $1.12 | 50,000 | 56,000 | 167,206 | Feb 26, 2015, 05:02 PM | |
| GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Dec 19, 2014 | Sale | $8.61 | 10,598 | 91,277 | 480,113 | Dec 23, 2014, 04:30 PM | |
| GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Dec 22, 2014 | Sale | $8.44 | 10,659 | 89,913 | 469,454 | Dec 23, 2014, 04:30 PM | |
| GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Dec 15, 2014 | Option Exercise | $0.64 | 45,232 | 28,801 | 497,436 | Dec 17, 2014, 06:10 PM | |
| GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Dec 17, 2014 | Sale | $8.97 | 5,121 | 45,935 | 490,711 | Dec 17, 2014, 06:10 PM | |
| GLYC | GLYCOMIMETICS INC | King Rachel K. | President, CEO | Jun 18, 2014 | Option Exercise | $1.12 | 100,000 | 112,000 | 108,706 | Jun 20, 2014, 04:00 PM | |
| GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Jun 12, 2014 | Buy | $6.54 | 6,000 | 39,240 | 7,562 | Jun 13, 2014, 04:01 PM | |
| GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Jun 13, 2014 | Buy | $6.21 | 5,000 | 31,050 | 12,562 | Jun 13, 2014, 04:01 PM | |
| GLYC | GLYCOMIMETICS INC | HENOS MICHAEL A | Director | Apr 03, 2014 | Option Exercise | $1.12 | 1,562 | 1,749 | 1,562 | Apr 03, 2014, 04:38 PM | |
| GLYC | GLYCOMIMETICS INC | BARRIS PETER J | 10% Owner | Jan 15, 2014 | Buy | $8.00 | 487,500 | 3,900,000 | 4,481,758 | Jan 15, 2014, 05:16 PM | |
| GLYC | GLYCOMIMETICS INC | BARRIS PETER J | 10% Owner | Jan 15, 2014 | Buy | $8.00 | 512,500 | 4,100,000 | 4,093,377 | Jan 15, 2014, 05:16 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Jan 15, 2014 | Buy | $8.00 | 487,500 | 3,900,000 | 4,481,758 | Jan 15, 2014, 05:15 PM | |
| GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Jan 15, 2014 | Buy | $8.00 | 512,500 | 4,100,000 | 4,093,377 | Jan 15, 2014, 05:15 PM | |
| GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Jan 15, 2014 | Buy | $8.00 | 487,500 | 3,900,000 | 4,481,758 | Jan 15, 2014, 05:15 PM | |
| GLYC | GLYCOMIMETICS INC | BARRETT M JAMES | Director | Jan 15, 2014 | Buy | $8.00 | 512,500 | 4,100,000 | 4,093,377 | Jan 15, 2014, 05:15 PM | |
| GLYC | GLYCOMIMETICS INC | BASKETT FOREST | 10% Owner | Jan 15, 2014 | Buy | $8.00 | 512,500 | 4,100,000 | 4,093,377 | Jan 15, 2014, 05:14 PM |
Menu